Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, explains the "L-arginine paradox" and acts as a novel cardiovascular risk factor

Journal of Nutrition

Volumn 134, Issue 10 SUPPL., 2004, Pages

  Böger, Rainer H ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Atherosclerosis; Coronary heart disease; Endothelium; Nitric oxide; Oxidative stress; Prognosis

Indexed keywords

ARGININE; C REACTIVE PROTEIN; CITRULLINE; DIMETHYLARGININASE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; S ADENOSYLMETHIONINE;

AMINO ACID METABOLISM; ARTERY DISEASE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MICHAELIS CONSTANT; NONHUMAN; PULMONARY HYPERTENSION; STROKE; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 4744339386     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/134.10.2842s     Document Type: Conference Paper

References (61)

1. Böger, R. H., Bode-Böger, S. M., Szuba, A., Tangphao, O., Tsao, P. S., Chan, J. R., Blaschke, T. F. & Cooke, J. P. (1998) ADMA: a novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation 98: 1842-1847.
2. Panza, J. A., Quyyumi, A. A., Brush, J. E. & Epstein, S. E. (1990) Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N. Engl. J. Med. 323: 22-27.
3. Celermajer, D. S., Sorensen, K. E., Georgakopoulos, D., Bull, C., Thomas, O., Robinson, J. & Deanfield, J. E. (1993) Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation 88: 2149-2155.
4. Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K. & Creager, M. A. (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516.
5. Tawakol, A., Omland, T., Gerhard, M., Wu, J. T. & Creager, M. A. (1997) Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95: 1119-1121.
6. Hingorani, A. D., Cross, J., Kharbanda, R. K., Mullen, M. J., Bhagat, K., Taylor, M., Donald, A. E., Palacios, M., Griffin, G. E. et al. (2000) Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 102: 994-999.
7. Vallance, P., Leone, A., Calver, A., Collier, J. & Moncada, S. (1992) Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet 339: 572-575.
8. Cooke, J. P., Andon, N. A., Girerd, X. J., Hirsch, A. T. & Creager, M. A. (1991) Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation 83: 1057-1062.
9. Böger, R. H., Bode-Böger, S. M., Mügge, A., Kienke, S., Brandes, R., Dwenger, A. & Frölich, J. C. (1995) Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. Atherosclerosis 117: 273-284.
10. Böger, R. H., Bode-Böger, S. M., Phivthong-ngam, L., Böhme, M., Brandes, R. P., Mügge, A. & Frölich, J. C. (1997) Dietary L-arginine slows the progression of atherosclerosis in cholesterol-fed rabbits-comparison with lovastatin. Circulation 96: 1282-1290.
11. Candipan, R. C., Wang, B. Y., Buitrago, R., Tsao, P. S. & Cooke, J. P. (1996) Regression or progression. Dependency on vascular nitric oxide. Arterioscler. Thromb. Vasc. Biol. 16: 44-50.
12. Tsao, P. S., Theilmeier, G., Singer, A. H., Leung, L. L. & Cooke, J. P. (1994) L-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler. Thromb. 14: 1529-1533.
13. Tsao, P. S., McEvoy, L. M., Drexler, H., Butcher, E. C. & Cooke, J. P. (1994) Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 89: 2176-218.
14. Böger, R. H., Bode-Böger, S. M., Kienke, S., Nafe, R., Stan, A. C. & Frölich, J. C. (1998) Dietary L-arginine decreases myointimal cell proliferation and vascular leukocyte accumulation in cholesterol-fed rabbits. Atherosclerosis 136: 67-77.
15. Mügge, A. & Harrison, D. G. (1991) L-Arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro. Blood Vessels 28: 354-357.
16. Pollock, J. S., Förstermann, U., Mitchell, J. A., Warner, T. D., Schmidt, H. H., Nakane, M. & Murad, F. (1991) Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 88: 10480-10484.
17. Böger, R. H. & Bode-Böger, S. M. (2001) The clinical pharmacology of L-arginine. Annu. Rev. Pharmacol. 41: 79-99.
18. Jeserich, M., Münzel, T., Just, H. & Drexler, H. (1992) Reduced plasma L-arginine in hypercholesterolemia. Lancet 339: 561.
19. Tsikas, D., Böger, R. H., Sandmann, J., Bode-Böger, S. M. & Frölich, J. C. (2000) Hypothesis: endogenous nitric oxide synthase inhibitors are responsible for the L-arginine paradox. FEBS Lett. 23810: 1-3.
20. Kurose, I., Wolf, R., Grisham, M. B. & Granger, D. N. (1995) Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. Am. J. Physiol. 268: H2224-H2231.
21. Faraci, F. M., Brian, J. E. & Heistad, D. D. (1995) Response of cerebral blood vesels to an endogenous inhibitor of nitric oxide synthase. Am. J. Physiol. 269: H1522-H1527.
22. Segarra, G., Medina, P., Ballester, R. M., Lluch, P., Aldasoro, M., Vila, J. M., Lluch, S. & Pelligrino, D. A. (1999) Effects of some guanidino compounds on human cerebral arteries. Stroke 30: 2206-2211.
23. Vallance, P., Leone, A., Calver, A., Collier, J. & Moncada, S. (1992) Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J. Cardiovasc. Pharmacol. 20 (suppl. 12): S60-S62.
24. G-dimethylarginine by human endothelial cells. Endothelium 1: 137-140.
25. Tsikas, D., Sandmann, J., Böger, R. H. Gutzki, F. M., Mayer, B. & Frölich, J. C. (2000) Assessment of nitric oxide synthase activity by gas chromatography-mass spectrometry. J. Chromatogr. B 742: 143-153.
26. MacAllister, R. J., Parry, H., Kimoto, M. T., Russell, R. J., Hodson, H., Whitley, G. S. & Vallance, P. (1996) Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br. J. Pharmacol. 119: 1533-1540.
27. Lin, P. S., Böger, R. H., Bode-Böger, S. M., Tsao, P. S. & Cooke, J. P. (1997) Asymmetric dimethylarginine enhances superoxide production in human endothelial cells. Circulation 96 (suppl.): I-45 (abs.).
28. Dayoub, H., Achan, V., Adimoolam, S., Jacobi, J., Stühlinger, M. C., Wang, B. Y., Tsao, P. S., Kimoto, M., Vallance, P. et al. (2003) Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence. Circulation 108: 3042-3047.
29. Calver, A., Collier, J., Leone, A., Moncada, S. & Vallance, P. (1993) 1993. Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers. J. Hum. Hypertens. 7: 193-194.
30. Achan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R. & Vallance, P. (2003) Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolised by dimethylarginine dimethylaminohydolase. Arterioscler. Thromb. Vasc. Biol. 23: 1455-1459.
31. Kielstein, J. T., Impraim, B., Simmel, S., Bode-Böger, S. M., Tsikas, D., Frölich, J. C., Höper, M. M., Haller, H. & Frölich, J. C. (2004) Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 109: 172-177.
32. Böger, R. H. (2003) The emerging role of ADMA as a novel cardiovascular risk factor. Cardiovasc. Res. 59: 824-833.
33. Aletta, J. M., Cimato, T. R. & Ettinger, M. J. (1998) Protein methylation: a signal event in post-translational modification. Trends Biochem. Sci. 23: 89-91.
34. Kielstein, J. T. Böger, R. H., Bode-Böger, S. M., Schäffer, J., Barbey, M., Koch, K. M. & Frölich, J. C. (1999) Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J. Am. Soc. Nephrol. 10: 594-600.
35. Zoccali, C., Bode-Böger, S. M., Mallamaci, F., Benedetto, F. A., Tripepi, G., Malatino, L., Cataliotti, A., Bellanuova, I., Fermo, I., Frölich, J. C. & Böger, R. H. (2001) Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of nitric oxide synthase predicts mortality in end-stage renal disease (ESRD). Lancet 358: 2113-2117.
36. G-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal antibody. J. Biochem. 117: 237-238.
37. Leiper, J. M., Santa Maria, J., Chubb, A., MacAllister, R. J., Charles, I. G., Whitley, G. S. & Vallance, P. (1999) Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases. Biochem. J. 343: 209-214.
38. Ito, A., Tsao, P. S., Adimoolam, S., Kimoto, M., Ogawa, T. & Cooke, J. P. (1999) Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation 99: 3092-3095.
39. Leiper, J., Murray-Rust, J., McDonald, N. & Vallance, P. (2002) S-Nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase. Proc. Natl. Acad. Sci. U.S.A. 99: 13527-13532.
40. Sydow, K., Schwedhelm, E., Arakawa, N., Bode-Böger, S. M., Tsikas, D., Hornig, B., Frölich, J. C. & Böger, R. H. (2003) ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia. Effects of L-arginine and B vitamins. Cardiovasc. Res. 57: 244-252.
41. Abbasi, F., Asagmi, T., Cooke, J. P., Lamendola, C., McLaughlin, T., Reaven, G. M., Stühlinger, M. & Tsao, P. S. (2001) Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am. J. Cardiol. 88: 1201-1203.
42. Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K. & Frölich, J. C. (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95: 2068-2074.
43. Goonasekera, C. D., Rees, D. D., Woolard, P., Frend, A., Shah, V. & Dillon, M. J. (1997) Nitric oxide synthase inhibitors and hypertension in children and adolescents. J. Hypertens. 15: 901-909.
44. Surdacki, A., Nowicki, M., Sandmann, J., Tsikas, D., Böger, R. H., Bode-Böger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. & Frölich, J. C. (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetrical dimethylarginine in men with essential hypertension. J. Cardiovasc. Pharmacol. 33: 652-658.
45. Usui, M., Matsuoka, H., Miyazaki, H., Ueda, S., Okuda, S. & Imaizumi, T. (1998) Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci. 62: 2425-2430.
46. Valkonen, V. P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimaki, T., Laakso, J. & Laaksonen, R. (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127-2128.
47. Miyazaki, H., Matsuoka, H. & Cooke, J. P. (1999) Endogenous nitric oxide synthase inhibitor. A novel marker of atherosclerosis. Circulation 99: 1141-1146.
48. Zoccali, C., Benedetto, F. A., Maas, R., Mallamaci, F., Tripepi, G., Malatino, L., Fermo, I. & Böger, R. H. (2002) Asymmetric dimethylarginine (ADMA), C-reactive protein, and carotid intima media-thickness in end-stage renal disease. J. Am. Soc. Nephrol. 13: 490-496.
49. Böger, R. H., Lenzen, H., Hanefeld, C., Bartling, A., Osterziel, K. J., Kusus, M., Schmidt-Lucke, C., Strödter, D., Berger, J. et al. (2004) Asymmetric dimethylarginine and the risk of coronary heart disease: relationship with traditional risk factors as assessed in the multicenter CARDIAC study. J. Am. Coll. Cardiol. 43 (suppl.): 515A (abs.).
50. Nijveldt, R. J., Teerlink, T., van der Hoven, B., Siroen, M. P., Kuik, D. J., Rauwerda, J. A. & van Leeuwen, P. A. (2003) Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clin. Nutr. 22: 23-30.
51. Lu, T. M., Ding, Y. A., Lin, S. J., Lee, W. S. & Tai, H. C. (2003) Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention. Eur. Heart J. 24: 1912-1919.
52. Hornig, B., Arakawa, N., Böger, R. H., Bode-Böger, S. M., Frölich, J. C. & Drexler, H. (1998) Plasma levels of ADMA are increased and inversely related to endothelium-mediated vasodilation in patients with chronic heart failure: a new predictor of endothelial dysfunction? Circulation 98 (suppl.): I-318 (abs.).
53. Azuma, H., Sato, J., Hamasaki, H., Sugimoto, A., Isotani, E. & Obayashi, S. (1995) Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br. J. Pharmacol. 115: 1001-1004.
54. el-Tamimi, H., Davies, G. J., Crea, F. & Maseri, A. (1993) Response of human coronary arteries after injury by coronary angioplasty. J. Am. Coll. Cardiol. 21: 1152-1157.
55. Schwarzacher, S. P., Lim, T. T., Wang, B., Kernoff, R. S., Niebauer, J., Cooke, J. P. & Yeung, A. C. (1997) Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 95: 1863-1969.
56. Laufs, U., La, F., Plutzky, J. & Liao, J. K. (1998) Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135.
57. Janatuinen, T., Laakso, J., Laaksonen, R., Nuutila, P., Lehtimaki, T., Raitakari, O. T. & Knuuti, J. (2003) 2003. Plasma asymmetric dimethylarginine modifies the effect of pravastatin on myocardial blood flow in young adults. Vasc. Med. 2003; 8: 185-189.
58. Böger, R. H. (2003) Asymmetric dimethylarginine (ADMA) modulates endothelial function-therapeutic implications [Editorial]. Vasc. Med. 8: 149-151.
59. Böger, G. I., Maas, R., Schwedhelm, E., Bierend, A., Benndorf, R., Kastner, M., Steenpaß, A., & Böger, R. H. (2004) Improvement of endothelium-dependent vasodilation by simvastatin is potentiated by combination with L-arginine in patients with elevated asymmetric dimethylarginine levels. J. Am. Coll. Cardiol. 43 (suppl.): 525A (abs.).
60. ADMA Spiegel [Online]. www.adma-spiegel.de [accessed April 28, 2004].
61. DLD Diagnostika [Online]. www.dld-diagnostika.de [accessed April 28, 2004].